Dendrimers for biomedical applications
2023 Activity indicators
- 13 competitive public projects: ISCIII, MICINN, CAM, CAM-UAH y UAH
- 1 private project led
- 8 competitive HR contracts
- 20 publications
- IF: 106.52
- Q1 publications: 15 (75%)
- D1 publications: 2 (10%)
- Evaluators of projects in European and national public institutions: 4 PI
- Member of editorial committees: 3 researchers
- 3 patents
- 5 months stay in foreign centres:
- Freie Universitat Berlin (Germany)
- Western University London (Canada)
Milestones
-
Start of the public competitive project in the framework of the call for R&D programmes in biomedicine 2022 of the CAM: New therapeutic solutions for the treatment of radiated skin. Ref. CAM_Radioprotect_P2022/BDM-7406.
-
Incorporation of Dr. Silvia Moreno as a distinguished researcher 'Beatriz Galindo Junior'. Dr. Moreno has extensive international experience in the field of macromolecular chemistry for biomedical applications.
-
Consolidation of the research line established with the pharmaceutical company Berlimed S.L. through the formalisation of a new Industrial Doctorate co-funded by the Community of Madrid.
-
Sandra García-Gallego et al. Shell Formulation in Soft Gelatin Capsules: Design and Characterization. Advanced Healthcare Materials 2023. DOI: 10.1002/adhm.202302250. PMID: 37775861.
-
1 granted patent ES2932900- 'Extraction and purification of proteins with magnetic nanoparticles stabilised with carbosilane dendritic systems', 1 applied for patent EP23383337-'Stable soft capsule preparations with solid fill for moisture sensitive active ingredients' and a PCT extension ES2940914B2-'Hydrogels with dendritic domains of carbosilane nature, their preparation and their uses'.
Bibliometrics
ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
---|---|---|---|---|---|---|---|
2019 | 20 | 88.94 | 4.45 | 19 | 95 | 1 | 5 |
2020 | 32 | 141.92 | 4.43 | 32 | 100 | 4 | 13 |
2021 | 16 | 83.21 | 5.20 | 15 | 94 | 3 | 19 |
2022 | 18 | 119.13 | 6.62 | 18 | 100 | 3 | 17 |
2023 | 20 | 106.52 | 6.27 | 17 | 85 | 2 | 10 |
106 | 539.72 | 5.39 | 101 | 95 | 13 | 12 |
* Only original articles, editorial material, guidelines and reviews.